Opening DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
- Length
- 1 h 33 min
- Level
- Undergraduate
- Recorded
- Christian Medical College Vellore2024
Chapter 1 of 12: Study outcomes in clinical trials
Bangdiwala weighs composite, surrogate and repeated-time-point outcomes against the type I error each one risks.
Choosing the primary outcome of a clinical trial starts with separating the clinical endpoint from the outcome variable used to measure it. Bangdiwala, Professor of Biostatistics, shows how one clinical event becomes a binary, count, time-to-event or composite variable, with the Kaplan-Meier curve for survival measures. He sets secondary and safety outcomes apart from effectiveness, and draws on the SOLVD Study and a 2003 special communication on composite outcomes. Surrogate outcomes, bioequivalence studies, quality-of-life scales and multiple time points follow, along with FDA guidance on hierarchical testing and co-primary endpoints. The session, part of the Clinical Trials Course 2023 at Christian Medical College Vellore, assumes basic trial design and hypothesis testing.
Choosing the primary outcome of a clinical trial starts with separating the clinical endpoint from the outcome variable used to measure it. Bangdiwala, Professor of Biostatistics, shows how one clinical event becomes a binary, count, time-to-event or composite variable, with the Kaplan-Meier curve for survival measures. He sets secondary and safety outcomes apart from effectiveness, and draws on the SOLVD Study and a 2003 special communication on composite outcomes. Surrogate outcomes, bioequivalence studies, quality-of-life scales and multiple time points follow, along with FDA guidance on hierarchical testing and co-primary endpoints. The session, part of the Clinical Trials Course 2023 at Christian Medical College Vellore, assumes basic trial design and hypothesis testing.
Composite Outcomes in Randomized Trials
Multiple Endpoints in Clinical Trials Guidance for Industry
Composite Outcomes in Randomized Trials Greater Precision But With Greater Uncertainty?
Guidance for Industry of the FDA
SOLVD Study
Variability magnitude of effect of interventions across categories of the sport and patient

This lecture
Lecture 9 of 14 of Clinical Trials Course - 2023.
Choose a node to see how it connects to this lecture. What comes before is on the leftat the top. What comes after is on the rightat the bottom. The ring is what it teaches. People and places are above. Other lectures and books are below.
Press a chosen node again to open it.
Your comment is kept while you sign up.Sign in